Welcome to our dedicated page for Venus Concept SEC filings (Ticker: VERO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Venus Concept Inc. (NASDAQ: VERO) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. Venus Concept is a medical aesthetic technology company that files a range of documents with the U.S. Securities and Exchange Commission, including Current Reports on Form 8-K, annual reports on Form 10-K and quarterly reports on Form 10-Q.
For Venus Concept, Form 8-K filings are particularly important because they document material events such as bridge loan amendments, consent agreements, delayed drawdowns, debt-to-equity exchanges and amendments to preferred stock designations. Recent 8-Ks describe multiple amendments to the company’s Main Street Priority Loan and Bridge Loan with affiliates of Madryn Health Partners, waivers of minimum liquidity covenants, and extensions of loan maturity dates. Other 8-Ks report the exchange of subordinated convertible notes for shares of Series Y Convertible Preferred Stock and changes to the certificate of designations for that preferred stock.
Investors can also use this page to locate earnings-related filings, such as 8-Ks furnished under Item 2.02 that attach press releases for quarterly results, where Venus Concept discusses revenue by region (United States and International), revenue by product category (Venus Prime / subscription systems, products – systems, products – other, and services), gross profit and operating loss. These filings complement the more detailed financial statements and risk disclosures found in the company’s 10-Q and 10-K reports.
Stock Titan enhances these documents with AI-powered summaries and highlights, helping readers quickly identify key points in long filings, such as new financing terms, covenant waivers, strategic transaction agreements (including the definitive agreement to sell the Venus Hair business), and changes to capital structure. Users can also review insider and related-party information where reported, and track how Venus Concept’s financing arrangements and strategic initiatives evolve over time through successive filings.
Madryn Asset Management and affiliated funds have taken Venus Concept Inc. private through a short-form merger and now beneficially own 56,991,898 shares of common stock, representing 100% of the class. In the March 30, 2026 merger, each common share not owned by the reporting persons was converted into the right to receive cash of $0.04 per share.
Leading up to this, the funds repeatedly exchanged debt for preferred stock and convertible notes, then on March 26, 2026 purchased 37,500,000 new common shares from the company for $1,500,000 at $0.04 per share and acquired all of HealthQuest’s and EW Healthcare’s equity and convertible debt positions. After the merger, the reporting persons also own all series of Venus Concept’s preferred stock, and the company’s charter was amended to effect a 1000-to-1 reverse stock split and reduce authorized shares.
Venus Concept Inc. reported that investment funds affiliated with Madryn Asset Management, as ten percent owners, made sizeable indirect purchases of common and convertible securities. Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP bought 37,500,000 shares of common stock for $1,500,000 under a Stock Purchase Agreement, at $0.04 per share. They also acquired Voting Convertible Preferred Stock, Senior Convertible Preferred Stock and Secured Subordinated Convertible Notes from existing investors for cash and promissory-note consideration. The preferred shares are convertible into common stock at fixed ratios, and the notes have an aggregate principal of $2,611,228.33 plus accrued interest and are convertible into 189,756 shares of common stock. All securities are held by the Madryn funds; Madryn Asset Management, LP and Madryn Health Advisors, LP may be deemed beneficial owners but each reporting person disclaims beneficial ownership except to the extent of its pecuniary interest.
Venus Concept, Inc. shareholder EW Healthcare/Essex Woodlands has updated its ownership and disclosed a new securities sale agreement. The reporting group now beneficially owns 100,037 shares of Venus Concept common stock, representing 5.4% of the class, based on 1,859,123 shares outstanding as of November 7, 2025.
On March 26, 2026, EW Healthcare Partners and affiliates entered into a Securities Purchase Agreement with Madryn Asset Management and its affiliates. Madryn agreed to purchase voting convertible preferred common stock, senior convertible preferred stock and secured subordinated convertible notes for a total purchase price of $2,600,000, payable in four cash installments of $650,000 each at 18, 24, 30 and 36 months after March 26, 2026.
Venus Concept Inc. large shareholders associated with EW Healthcare Partners reported selling several convertible securities linked to the company. Through a Securities Purchase Agreement dated March 26, 2026, EW Healthcare Partners funds sold these instruments to Madryn entities for an aggregate $2,600,000 purchase price.
The sale covered 1,500,000 shares of Junior Convertible Preferred Stock, which are convertible into shares of Common Stock at a ratio of 0.0606, and 1,575,810 shares of Senior Convertible Preferred Stock, convertible at a ratio of 0.2424. They also sold secured subordinated convertible notes with aggregate principal and interest of $2,694,091.31, which are convertible into 195,777 shares of Common Stock.
The reporting entities held these securities indirectly through EW Healthcare funds and related general partners. Following the transactions, the filing shows zero remaining balance for each of the reported derivative positions.
EW Healthcare Partners and its affiliates filed Amendment No. 16 to their Schedule 13D on Venus Concept, Inc., updating their beneficial ownership and future plans. The group reports beneficial ownership stakes calculated against 1,859,123 common shares outstanding as of November 7, 2025, with individual reporting entities showing up to 21.4% of the class when including convertible and exercisable securities.
On March 16, 2026, EW Healthcare entities agreed a non-binding term sheet with Madryn Asset Management for Madryn to purchase all Venus Concept preferred stock and secured subordinated convertible notes held by the EW Healthcare sellers. The aggregate purchase price is $2,600,000, payable in four cash installments of $650,000 each, due 18, 24, 30 and 36 months after closing. Aside from this contemplated transaction, the reporting group states it has no present plans for other major corporate actions, while reserving flexibility to reassess over time.
Madryn Asset Management and affiliates report beneficial ownership of 18,763,125 Venus Concept common shares, representing 91.0% of the class. Through various Madryn funds, they hold large stakes, including 11,820,525 shares (57.3%) at Madryn Health Partners (Cayman Master) and 6,942,600 shares (33.7%) at Madryn Health Partners.
The filing details a multi‑year restructuring in which Madryn acquired the company’s MSLP loan, exchanged debt into preferred stock, and secured extensive registration and voting rights. Madryn has discussed cost reductions, including possible delisting and deregistration of the common stock.
Non‑binding term sheets with HealthQuest and EW contemplate Madryn buying their preferred equity and convertible debt for $755,646.90 (via 4% PIK notes) and $2,600,000 in deferred cash installments. A March 2026 proposal would inject $1.0 million at $0.01 per share, taking Madryn above 90% ownership and enabling a short‑form merger in which each common share would receive $0.01 in cash.